Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Orchid Pharma Limited has filed its financial results with the stock exchange for the quarter and period ending December 31, 2025. The announcement is a regulatory disclosure confirming submission, but the detailed numbers (revenue, profit, margins) are not included in this filing notice. Investors will need to refer to the full financial results document or the company's BSE/NSE filing for actual performance figures. The filing represents compliance with listing obligations requiring periodic disclosure of financial performance.
Without the actual numbers in this notice, there is no immediate impact to gauge. Investors should look at the detailed results PDF to assess revenue trends, profitability, and any one-time items before making decisions. Stock reaction will depend on how the figures compare to expectations.